Condition

Idiopathic Inflammatory Myopathy clinical trials and research

• 2Clinical trials
• 5Countries

All recruiting trials (2)

• Off-the-shelf CAR T-cell treatment (ALLO-329) for adults with lupus, inflammatory myopathy, or systemic sclerosis

  This trial tests ALLO-329, an off-the-shelf CAR T-cell therapy, to see if it is safe and helps adults with active SLE (with or without kidney involvement), idiopathic inflammatory myopathy, or systemic sclerosis.

  Recruiting at 17 sites Phase 1 Allogene Therapeutics · Phoenix, Arizona and 17 other locations · NCT07085104

• Evaluating CABA-201 for treating active idiopathic inflammatory myopathy

  This study is testing a new cell therapy called CABA-201 to see if it can help people with active idiopathic inflammatory myopathy feel better by reducing muscle inflammation and weakness.

  Recruiting at 35 sites Phase 2/3 Cabaletta Bio · Orange, California and 37 other locations · NCT06154252

Related topics

Quick answers

How many Idiopathic Inflammatory Myopathy clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 5 countries. The most sites are in United States (2 trials), Canada (1 trial), Germany (1 trial), Italy (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →